Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk factors associated with invasive orthopaedic interventions in males with haemophilia enrolled in the Universal Data Collection program from 2000 to 2010.
Tobase P, Lane H, Siddiqi AE, Soucie JM, Ingram-Rich R, Ward S, Gill JC; Hemophilia Treatment Center Network (HTCN) Study Investigators. Tobase P, et al. Among authors: lane h. Haemophilia. 2018 Nov;24(6):964-970. doi: 10.1111/hae.13511. Epub 2018 Jun 29. Haemophilia. 2018. PMID: 29957840 Free PMC article.
Functional outcomes following ankle arthrodesis in males with haemophilia: analyses using the CDC's Universal Data Collection surveillance project.
Lane H, Siddiqi AE, Ingram-Rich R, Tobase P, Scott Ward R; Universal Data Collection Joint Outcome Working Group; Hemophilia Treatment Center Network Study Investigators. Lane H, et al. Haemophilia. 2014 Sep;20(5):709-15. doi: 10.1111/hae.12398. Epub 2014 Mar 16. Haemophilia. 2014. PMID: 24629136 Free PMC article.
Declining trends in invasive orthopedic interventions for people with hemophilia enrolled in the Universal Data Collection program (2000-2010).
Tobase P, Lane H, Siddiqi AE, Ingram-Rich R, Ward RS; Universal Data Collection Joint Outcome Working Group, Hemophilia Treatment Center Network (HTCN) Study Investigators. Tobase P, et al. Among authors: lane h. Haemophilia. 2016 Jul;22(4):604-14. doi: 10.1111/hae.12932. Epub 2016 Mar 31. Haemophilia. 2016. PMID: 27030396 Free PMC article.
The effect of secondary prophylaxis versus episodic treatment on the range of motion of target joints in patients with haemophilia.
Gupta S, Siddiqi AE, Soucie JM, Manco-Johnson M, Kulkarni R, Lane H, Ingram-Rich R, Gill JC; Joint Outcomes Committee of Universal Data Collection and the Hemophilia Treatment Centres Network. Gupta S, et al. Among authors: lane h. Br J Haematol. 2013 May;161(3):424-33. doi: 10.1111/bjh.12267. Epub 2013 Feb 22. Br J Haematol. 2013. PMID: 23432684 Free PMC article.
Ramelteon protects against social defeat stress-associated abnormal behaviors.
Chen CW, Yeh WL, Charoensaensuk V, Lin C, Yang LY, Xie SY, Lane HY, Lin CH, Wang YW, Tsai CF, Lu DY. Chen CW, et al. Among authors: lane hy. Pharmacol Biochem Behav. 2024 Jun 2:173794. doi: 10.1016/j.pbb.2024.173794. Online ahead of print. Pharmacol Biochem Behav. 2024. PMID: 38834160
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. Among authors: lane hc. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
1,155 results